Recombinant Human Active GSK-3 beta Protein, CF

Catalog # Availability Size / Price Qty
2506-KS-010
Recombinant Human Active GSK-3 beta Protein SDS-PAGE
1 Image
Product Details
Citations (1)
FAQs
Reviews (1)

Recombinant Human Active GSK-3 beta Protein, CF Summary

Product Specifications

Purity
>70%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.
Activity
The specific activity of GSK-3 beta was determined to be 224 nmol/min/mg using a synthetic peptide substrate (YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE).
Source
Spodoptera frugiperda, Sf 9 (baculovirus)-derived human GSK-3 beta protein
Accession #
N-terminal Sequence
Analysis
Using an N-terminal GST tag
SDS-PAGE
73 kDa

Product Datasheets

You must select a language.

x

2506-KS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

2506-KS

Formulation Supplied in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.25 mM DTT, 10 mM glutathione, 0.1 mM EDTA, 0.1 mM PMSF, 25% glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: This product is stable at ≤ ‑70°C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

Assay Procedure

Materials
  • Active Kinase - Active GSK3 beta (0.1 μg/μL) diluted with Kinase Dilution Buffer 1X and assayed as outlined in sample activity plot. Note: These are suggested working dilutions. Optimal dilutions should be determined by each laboratory for each application.
  • Kinase Assay Buffer III - 200 mM Tris-HCl, pH 7.4, 100 mM MgCl2, and 5 mg/mL BSA. Add fresh DTT prior to use to a final concentration of 250 μM.
  • Kinase Dilution Buffer IX (1x)  - Kinase Assay Buffer III diluted at a 1:4 ratio (5-fold dilution) with cold water. Add fresh DTT to the aliquot prior to use to a final concentration of 50 μM.
  • 10 mM ATP Stock Solution - Prepare the ATP Stock Solution by dissolving 55 mg of ATP in 10 mL of Kinase Assay Buffer I.
  • ADP-GloTM Kinase Assay Kit - ATP Solution, 10 mM, ADP Solution, 10 mM, ADP-GloTM Reagent, Kinase Detection Reagent.
  • Substrate - GSK3 synthetic peptide substrate (YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE) diluted in distilled or deionized water to a final concentration of 1.0 mg/mL.
  1. Thaw the Active GSK3 beta, Kinase Assay Buffer III (5x), and Substrate on ice. Prepare a 15 μL enzyme dilution at the desired concentration, with Kinase Dilution Buffer IX (1x), in a pre-chilled 96-well plate.
  2. Prepare a substrate/ATP mixture as follows (25 μM example):
    a. 10 μM ATP Solution: 1.0 μL
    b. Kinase Assay Buffer III (5x): 79 μL
    c. Substrate at 1 mg/mL: 80 μL
  3. Transfer the following reaction components prepared in step 2 to a 384-well opaque plate bringing the reaction volume up to 5.0 μL:
    a. 3.0 μL of diluted Active GSK3 beta
    b. 2.0 μL of Substrate/ATP mix as prepared in Step 2. This initiates the reaction.
  4. Set up the blank control as outlined in step 2, excluding the addition of the kinase. Replace the kinase with an equal volume of Kinase Dilution Buffer IX (1x).
  5. Incubate at ambient temperature for 40 minutes.
  6. After the 40 minute incubation period, terminate the reaction and deplete the remaining ATP by adding 5.0 μL of ADP-GloTM Reagent. Spin down and shake the 384-well plate and incubate the reaction mixture for another 30 minutes at ambient temperature.
  7. Read the 384-well reaction plate using the Luminescence Module Protocol on a GloMax®-Multi Microplate Multimode Reader.
  8. Determine the corrected activity (RLU) by removing the blank control value (see step 4) for each sample and calculate the kinase specific activity as outlined below.


    Calculation of ADP Specific Activity (SA) (RLU/pmol)
    From ADP standard curve, determine RLU/pmol of ADP

    Calculation of Kinase Specific Activity (SA) (pmol/minutes/μg or nmol/minutes/mg)
    Corrected RLU from reaction / [(SA of ADP in RLU/pmol) x (Reaction time in minutes) x (Enzyme amount in μg or mg)]

Scientific Data

SDS-PAGE Recombinant Human Active GSK-3 beta Protein SDS-PAGE View Larger

The approximate molecular weight is 73 kDa and the purity is > 70%.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: GSK-3 beta

GSK-3 beta is a Serine/Threonine protein kinase that was originally identified as the kinase that phosphorylates and inhibits glycogen synthase (1). GSK-3 beta is ubiquitously present in human tissues and implicated in the regulation of several physiological processes, including the control of glycogen and protein synthesis by insulin and modulation of the transcription factors AP-1 and CREB. Transient transfection of human GSK-3 beta into Chinese hamster ovary cells stably transfected with individual human tau isoforms leads to hyperphosphorylation of tau at all the sites investigated with phosphorylation-dependent anti-tau antibodies (2).

References
  1. Sutherland, C. et al. (1993) Biochem. J. 296:15.
  2. Sperber, B.R. et al. (1995) Neurosci. Lett. 197:149.
Long Name
Glycogen Synthase Kinase 3 beta
Entrez Gene IDs
2932 (Human); 56637 (Mouse); 84027 (Rat)
Alternate Names
EC 2.7.11; EC 2.7.11.26; glycogen synthase kinase 3 beta; glycogen synthase kinase-3 beta; GSK3 beta; GSK-3 beta; GSK3B; GSK3beta isoform

Citation for Recombinant Human Active GSK-3 beta Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

1 Citation: Showing 1 - 1

  1. A SNP in steroid receptor coactivator-1 disrupts a GSK3beta phosphorylation site and is associated with altered tamoxifen response in bone.
    Authors: Hartmaier RJ, Richter AS, Gillihan RM, Sallit JZ, McGuire SE, Wang J, Lee AV, Osborne CK, O'Malley BW, Brown PH, Xu J, Skaar TC, Philips S, Rae JM, Azzouz F, Li L, Hayden J, Henry NL, Nguyen AT, Stearns V, Hayes DF, Flockhart DA, Oesterreich S
    Mol. Endocrinol., 2011-12-15;26(2):220-7.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Enzyme Assay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human Active GSK-3 beta Protein, CF

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Human Active GSK-3 beta Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Human Active GSK-3 beta Protein, CF
By Sayed Ala Moududee on 10/24/2023
Application: Binding assay/Protein-protein interaction
Reason for Rating: good quality